Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs
- 2 December 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 96 (3-4) , 211-226
- https://doi.org/10.1016/0014-2999(83)90310-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents: Part II: Sites and mechanisms of action of dopamine receptor agonistsLife Sciences, 1982
- Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents: Part I: Subclassification and functional descriptionLife Sciences, 1982
- Effects of Pergolide, A Dopamine Receptor Agonist, and Clondine on Cardiovascular Responses Evoked by Activation of Peripheral Sympathetic Outflow in RatsClinical and Experimental Hypertension. Part A: Theory and Practice, 1982
- Dopaminergic inhibition of cardiac sympathetic nerve function by pergolideEuropean Journal of Pharmacology, 1982
- Inhibitory effects of pergolide on peripheral adrenergic neurotransmission in spontaneously hypertensive ratsLife Sciences, 1981
- Inhibition of peripheral adrenergic neurotransmission by lergotrile in spontaneously hypertensive ratsLife Sciences, 1981
- Clinical response of patients with galactorrhea to pergolide, a potent, long-acting dopaminergic ergot derivativeLife Sciences, 1981
- DOPAMINE‐INDUCED NEUROGENIC VASODILATATION IN THE INTACT HINDLEG OF THE DOGBritish Journal of Pharmacology, 1977
- Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrineNeuropharmacology, 1973
- Vasoconstrictor Fibre Discharge to Skeletal Muscle, Kidney, Intestine and Skin at Varying Levels of Arterial Baroreceptor Activity in the CatActa Physiologica Scandinavica, 1971